Article

Dr. Lee becomes new U-M chairman

Paul P. Lee, MD, JD, has been appointed chairman of the ophthalmology and visual sciences department and holder of the F. Bruce Fralick Professorship at the University of Michigan, Ann Arbor.

Ann Arbor, MI-Paul P. Lee, MD, JD, has been appointed chairman of the ophthalmology and visual sciences department and holder of the F. Bruce Fralick Professorship at the University of Michigan (U-M), Ann Arbor.

“An outstanding clinician and innovative leader, Dr. Lee is ideally suited to head a department that has grown rapidly and just recently opened a magnificent new facility for eye care, education, and vision research,” said James O. Woolliscroft, MD, dean of the U-M Medical School.

As chairman, Dr. Lee succeeds glaucoma specialist Paul R. Lichter, MD, who served in the role for 34 years and has been a mentor to Dr. Lee since his medical school days.

“The terrific work of Dr. Paul Lichter and the faculty positions us to help reshape the future of vision health and eye care,” Dr. Lee said. “It is a special privilege to help build on what he and the department have already accomplished.”

Dr. Lee previously was vice chairman of the ophthalmology department and the James Pitzer Gills III, MD, and Joy Gills Professor of Ophthalmology at Duke University, Durham, NC. In addition, he held appointments as director of applied health systems research for the Duke University Health System and as senior adviser to the chancellor. Among other administrative leadership positions at Duke, Dr. Lee was chairman of the finance committee of the physician practice and member of the executive management committee of the Duke University Health System.

Before joining Duke in 1997, Dr. Lee was with RAND, a nonprofit research organization in Santa Monica, CA, and was an associate professor at the University of Southern California School of Medicine.

Dr. Lee earned his medical degree from U-M and his law degree from Columbia University in 1986. He completed an internship in internal medicine at Harvard Medical School’s Beth Israel Hospital, Boston, and his ophthalmology residency at the Wilmer Eye Institute of Johns Hopkins Hospital, Baltimore. After his residency, Dr. Lee completed a glaucoma fellowship at the Massachusetts Eye and Ear Infirmary, Boston.

The new chairman serves on the American Board of Ophthalmology Board of Directors and also maintains a referral clinical practice for patients with complex cases of glaucoma.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.